156 related articles for article (PubMed ID: 19066635)
1. Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factors.
Gomez GG; Hickey MJ; Tritz R; Kruse CA
Gene Ther Mol Biol; 2008 Jun; 12(1):101-110. PubMed ID: 19066635
[TBL] [Abstract][Full Text] [Related]
2. Cellular and functional characterization of immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated synthesis of biologically active TGF-beta.
Gomez GG; Kruse CA
J Immunother; 2007 Apr; 30(3):261-73. PubMed ID: 17414317
[TBL] [Abstract][Full Text] [Related]
3. Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization.
Gomez GG; Varella-Garcia M; Kruse CA
Cancer Genet Cytogenet; 2006 Mar; 165(2):121-34. PubMed ID: 16527606
[TBL] [Abstract][Full Text] [Related]
4. Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification.
Read SB; Kulprathipanja NV; Gomez GG; Paul DB; Winston KR; Robbins JM; Kruse CA
J Interferon Cytokine Res; 2003 Jul; 23(7):379-93. PubMed ID: 14511464
[TBL] [Abstract][Full Text] [Related]
5. Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.
Paul DB; Read SB; Kulprathipanja NV; Gomez GG; Kleinschmidt-DeMasters BK; Schiltz PM; Kruse CA
J Neurooncol; 2003; 64(1-2):89-99. PubMed ID: 12952290
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors.
Gomez GG; Read SB; Gerschenson LE; Santoli D; Zweifach A; Kruse CA
Neuro Oncol; 2004 Apr; 6(2):83-95. PubMed ID: 15134622
[TBL] [Abstract][Full Text] [Related]
7. Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.
Schiltz PM; Gomez GG; Read SB; Kulprathipanja NV; Kruse CA
J Interferon Cytokine Res; 2002 Dec; 22(12):1209-16. PubMed ID: 12581494
[TBL] [Abstract][Full Text] [Related]
8. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).
Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A
J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cell clones isolated from hypoxia-selected renal proximal tubular cells.
Brooks C; Wang J; Yang T; Dong Z
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F243-52. PubMed ID: 16885151
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the in vitro sensitivity of human lymphoid and hematopoietic progenitors to L-leucyl-L-leucine methyl ester.
Pecora AL; Bordignon C; Fumagalli L; Radziejewski C; Small TN; Pekle K; O'Reilly RJ; Keever CA
Transplantation; 1991 Feb; 51(2):524-31. PubMed ID: 1994549
[TBL] [Abstract][Full Text] [Related]
11. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.
Hishii M; Kurnick JT; Ramirez-Montagut T; Pandolfi F
Clin Exp Immunol; 1999 Jun; 116(3):388-94. PubMed ID: 10361224
[TBL] [Abstract][Full Text] [Related]
12. Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells.
Kulprathipanja NV; Kruse CA
J Neuroimmunol; 2004 Aug; 153(1-2):76-82. PubMed ID: 15265665
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
[TBL] [Abstract][Full Text] [Related]
14. Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis.
Mariani L; Beaudry C; McDonough WS; Hoelzinger DB; Demuth T; Ross KR; Berens T; Coons SW; Watts G; Trent JM; Wei JS; Giese A; Berens ME
J Neurooncol; 2001 Jun; 53(2):161-76. PubMed ID: 11716068
[TBL] [Abstract][Full Text] [Related]
15. Regulation of hematopoiesis in vitro by alloreactive natural killer cell clones.
Bellone G; Valiante NM; Viale O; Ciccone E; Moretta L; Trinchieri G
J Exp Med; 1993 Apr; 177(4):1117-25. PubMed ID: 8459206
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and functional characterization of human T cell clones indirectly activated against adult pig islet cells.
Lindeborg E; Kumagai-Braesch M; Möller E
Xenotransplantation; 2006 Jan; 13(1):41-52. PubMed ID: 16497211
[TBL] [Abstract][Full Text] [Related]
17. Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures.
Topalian SL; Kasid A; Rosenberg SA
J Immunol; 1990 Jun; 144(11):4487-95. PubMed ID: 2160503
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of human alloreactive T cell clones.
Rohowsky-Kochan C; Bonagura V; Lewison A; King DW; Suciu-Foca N
Hum Immunol; 1984 Dec; 11(4):173-82. PubMed ID: 6239844
[TBL] [Abstract][Full Text] [Related]
19. Induction of lytic pathways in T cell clones derived from wild-type or protein tyrosine kinase Fyn mutant mice.
Lancki DW; Fields P; Qian D; Fitch FW
Immunol Rev; 1995 Aug; 146():117-44. PubMed ID: 7493751
[TBL] [Abstract][Full Text] [Related]
20. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
Altevogt P; Leidig S; Heckl-Oestreicher B
Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
